By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – German protein analysis and diagnostics firm Protagen and Bayer Schering Pharma today announced the closing of a cooperation contract for the discovery of biomarkers for endometriosis.

Terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.